Zobrazeno 21 - 30
of 281
pro vyhledávání: ''
Autor:
Claudio Codignola, Mario Scartozzi, Fausto Meriggi, Chiara Ogliosi, Giovanni Luca Ceresoli, Alberto Zaniboni, Giordano D. Beretta, Tiziana Prochilo, Alberto Caprioli, Anna Paola Fraccon
Publikováno v:
Tumori Journal. 103:443-448
Purpose Lung cancer is one of the leading causes of cancer-related death worldwide and, although targeted therapy with tyrosine kinase inhibitors has dramatically improved the rates of response and survival in advanced EGFR-mutated adenocarcinoma, th
Autor:
Paweł Rogala, Michał Wągrodzki, Tomasz Świtaj, Anna Klimczak, Paulina Jagodzińska-Mucha, Iwona Ługowska, Katarzyna Kozak, Piotr Rutkowski, Hanna Koseła-Paterczyk, Sławomir Falkowski
Publikováno v:
Tumori Journal. 103:231-235
Background Alveolar soft part sarcoma (ASPS) is a rare, highly vascularized soft tissue sarcoma characterized by a high frequency of metastatic disease and resistance to classical chemotherapy. The purpose of our analysis was to assess long-term suni
Hepatosplenic T-Cell Lymphoma with Coexistent Hepatitis B Infection: A Rare Clinicopathologic Entity
Publikováno v:
Tumori Journal. 102:S61-S64
Background Hepatosplenic T-cell lymphoma (HSTL) is a rare extranodal and systemic lymphoma derived from cytotoxic T cells usually of γδ T cell receptor type. It is characterized by primary extranodal disease with typical sinusoidal infiltration of
Autor:
Lisa Argnani, Pier Luigi Zinzani, Claudio Agostinelli, Letizia Gandolfi, Cinzia Pellegrini, Alessandro Broccoli
Publikováno v:
Tumori Journal. 102:S124-S127
Background Autoimmune manifestations may occur in patients with hairy cell leukemia (HCL), and some rare cases of polyarteritis nodosa and leukocytoclastic vasculitis have been reported. However, data regarding the treatment of these cutaneous manife
Autor:
Jordi Remon, Caroline Caramella, Benjamin Besse, Ludovic Lacroix, Christophe Massard, Nathalie Auger, Francesco Facchinetti, Julien Adam, David Planchard, Luc Friboulet, Jean-Charles Soria
Publikováno v:
Tumori Journal. 102:S46-S49
We report on the case of a patient affected by advanced non-small cell lung cancer (NSCLC) harboring an anaplastic lymphoma kinase (ALK) gene rearrangement who did not respond to crizotinib but subsequently benefited from treatment with ceritinib (LD
Autor:
Paul H. Sugarbaker
Publikováno v:
Tumori Journal. 102:588-592
Purpose Adrenal cortical carcinoma is a rare cancer that often presents in an advanced stage. Not only systemic metastases but also local recurrence and peritoneal metastases prevent long-term survival in these patients. Methods A profoundly symptoma
Publikováno v:
Tumori Journal. 103:261-267
Purpose Proteasome inhibition with bortezomib eliminates multiple myeloma (MM) cells by partly disrupting unfolded protein response (UPR). However, the development of drug resistance limits its utility and resistance mechanism remains controversial.
New Drugs in the Treatment of Elderly Patients with Metastatic Castration-Resistance Prostate Cancer
Publikováno v:
Tumori Journal. 102:361-366
Treatment of prostate cancer is continually evolving and new therapies have become available. However, the management of elderly patients is challenging due to their age and comorbidities. Androgen deprivation therapy remains the mainstay treatment o
Autor:
Osman Turkmen, Tolga Tasci, Taner Turan, Derman Basaran, Günsu Kimyon, Alper Karalok, Gökhan Tulunay, Isin Ureyen
Publikováno v:
Tumori Journal. 103:177-181
Objective To define the factors associated with methotrexate (MTX) resistance in patients with low-risk gestational trophoblastic neoplasia (GTN). Methods A total of 63 patients with low-risk GTN according to International Federation of Gynecology an
Autor:
Fabrizio Festinese, Giulia Galli, Giacomo Bregni, Antonia Martinetti, Luigi Mariani, Filippo de Braud, Arpine Gevorgyan, Monica Ganzinelli, Serena Di Cosimo, Elisa Sottotetti, Salvatore Lo Vullo
Publikováno v:
Tumori Journal. 102:e11-e14
Purpose Obesity is a known risk factor for breast cancer and has been linked to increased risk of recurrence and death in breast cancer patients. Little is known about the predictive value of obesity. As endocrine therapy is widely used for breast ca